Professional Focus

• Biomedical scientist specializing in immune and metabolic mechanisms underlying age-related degenerative eye diseases.

Key Discoveries & Innovations

• Led the discovery of IRAK-M as a gene therapy target for atrophic macular degeneration, opening new avenues for treatment.

• Pioneered the therapeutic use of topical trehalose to non-invasively enhance autophagy and preserve retinal health.

• Research published in leading journals, including Science Translational Medicine and Aging Cell.

Research Approach

• Bridge fundamental biology with translational medicine.

• Integrate expertise in immunoaging and therapeutic development.

• Reveal molecular pathways critical to retinal degeneration and propose novel strategies to slow or prevent disease progression.

Service

• PhD student supervisor. 

• Grant reviewer for major funding bodies including the MRC and BBSRC.

• Peer reviewer for high-impact journals such as: Signal Transduction & Targeted Therapy, Science Advances, Autophagy, Aging Cell, Molecular Therapy, etc. 

• Associate editor with Frontiers in Immunology and Topic editor with Cells.